MedPath

RIVA-PYRIDOSTIGMINE

RIVA-PYRIDOSTIGMINE

Approved
DIN Number

02495643

Drug Class

Human

Market Date

Aug 24, 2020

Company
HC

laboratoire riva inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02495643
AIG Number0107514003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N07AA02 PYRIDOSTIGMINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification12:04.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

PYRIDOSTIGMINE BROMIDEActive
Strength: 60 MG
Monograph: PYRIDOSTIGMINE BROMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.